BridgeBio Pharma, Inc. (BBIO) SEC filings

BBIO SEC filings moved a median of +0.56% by the close. BBIO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the BBIO overview →

69 measured BBIO SEC filing events.

Where these BBIO SEC filings landedvs 69 measured BBIO SEC filing reactions
BBIO SEC filingMiddle 50% · -1.77% to +1.63%Zero: 0.00%Median: +0.56%Median +0.56%-3.00%0+3.00%
Middle 50% of BBIO SEC filing reactions-1.77% to +1.63%
Median reaction (to close)+0.56%
Measured reactions69
Point-in-time · zero look-ahead

Half of the 69 BBIO SEC filing events with a measured close landed between -1.77% and +1.63%; 58% closed up.

DateHeadlineEvent5-minTo close
Form 8-K BridgeBio Pharma, Inc. For: Oct 06SEC filing · Form 8-K-0.75%-3.46%
Form 8-K BridgeBio Pharma, Inc. For: Aug 31SEC filing · Form 8-K-0.20%-0.20%
Form 8-K BridgeBio Pharma, Inc. For: Aug 13SEC filing · Form 8-K-0.13%+0.94%
Form S-3ASR BridgeBio Pharma, Inc.SEC filing · Form S-3ASR+0.76%+0.10%
Form S-8 BridgeBio Pharma, Inc.SEC filing · Form S-8+0.76%+0.10%
Form 8-K BridgeBio Pharma, Inc. For: Jul 22SEC filing · Form 8-K+0.35%+0.64%
Form 8-K BridgeBio Pharma, Inc. For: Jul 01SEC filing · Form 8-K+0.28%+0.28%
Form 8-K BridgeBio Pharma, Inc. For: Jun 22SEC filing · Form 8-K+1.45%+1.02%
Form 8-K BridgeBio Pharma, Inc. For: May 27SEC filing · Form 8-K-0.54%+3.01%
Form 8-K BridgeBio Pharma, Inc. For: May 12SEC filing · Form 8-K-0.30%+1.10%
Form 8-K BridgeBio Pharma, Inc. For: May 07SEC filing · Form 8-K+2.12%+1.29%
Form S-3ASR BridgeBio Pharma, Inc.SEC filing · Form S-3ASR+2.12%+1.29%
Form 10-Q BridgeBio Pharma, Inc. For: Mar 31SEC filing · Form 10-Q+2.12%+1.29%
Form 8-K BridgeBio Pharma, Inc. For: May 06SEC filing · Form 8-K+2.12%+1.29%
Form ARS BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form ARS+0.42%-1.77%
Form DEF 14A BridgeBio Pharma, Inc. For: Jun 22SEC filing · Form DEF+0.42%-1.77%
Form DEFA14A BridgeBio Pharma, Inc.SEC filing · Form DEFA14A+0.42%-1.77%
Form 8-K BridgeBio Pharma, Inc. For: Mar 30SEC filing · Form 8-K+1.44%+4.55%
Form 10-K BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form 10-K+0.47%-5.86%
Form 8-K BridgeBio Pharma, Inc. For: Feb 24SEC filing · Form 8-K+0.47%-5.86%
Form 8-K BridgeBio Pharma, Inc. For: Feb 12SEC filing · Form 8-K-3.53%-1.26%
Form 8-K BridgeBio Pharma, Inc. For: Jan 14SEC filing · Form 8-K+0.11%+2.38%
Form 8-K BridgeBio Pharma, Inc. For: Jan 12SEC filing · Form 8-K+0.03%+3.89%
Form 10-Q BridgeBio Pharma, Inc. For: Sep 30SEC filing · Form 10-Q+0.01%-4.09%
Form 8-K BridgeBio Pharma, Inc. For: Oct 29SEC filing · Form 8-K+0.01%-4.09%
Form 8-K BridgeBio Pharma, Inc. For: Oct 27SEC filing · Form 8-K+1.89%+2.23%
Form 10-Q BridgeBio Pharma, Inc. For: Jun 30SEC filing · Form 10-Q-2.47%+0.70%
Form 8-K BridgeBio Pharma, Inc. For: Aug 05SEC filing · Form 8-K-2.47%+0.70%
Form S-8 BridgeBio Pharma, Inc.SEC filing · Form S-8-2.47%+0.70%
Form 8-K BridgeBio Pharma, Inc. For: Jun 27SEC filing · Form 8-K-0.14%+0.97%
Form 8-K BridgeBio Pharma, Inc. For: Jun 20SEC filing · Form 8-K+0.02%+4.37%
Form DEFA14A BridgeBio Pharma, Inc.SEC filing · Form DEFA14A+1.11%+3.48%
Form ARS BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form ARS+1.29%-0.65%
Form DEF 14A BridgeBio Pharma, Inc. For: Jun 20SEC filing · Form DEF+1.29%-0.65%
Form DEFA14A BridgeBio Pharma, Inc.SEC filing · Form DEFA14A-2.84%+0.03%
Form 10-Q BridgeBio Pharma, Inc. For: Mar 31SEC filing · Form 10-Q+1.29%-0.65%
Form 8-K BridgeBio Pharma, Inc. For: Apr 29SEC filing · Form 8-K+1.29%-0.65%
Form PRE 14A BridgeBio Pharma, Inc. For: Jun 20SEC filing · Form PRE-0.33%+0.98%
Form 8-K BridgeBio Pharma, Inc. For: Mar 17SEC filing · Form 8-K+0.82%+1.20%
Form 8-K BridgeBio Pharma, Inc. For: Feb 24SEC filing · Form 8-K+0.20%-4.43%
Form 10-K BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form 10-K-2.54%-2.87%
Form 8-K BridgeBio Pharma, Inc. For: Feb 20SEC filing · Form 8-K-2.27%-6.59%
Form 8-K BridgeBio Pharma, Inc. For: Jan 13SEC filing · Form 8-K+2.09%+5.56%
Form 8-K BridgeBio Pharma, Inc. For: Nov 22SEC filing · Form 8-K+4.07%-5.10%
Form 10-Q BridgeBio Pharma, Inc. For: Sep 30SEC filing · Form 10-Q-1.76%-6.74%
Form 8-K BridgeBio Pharma, Inc. For: Nov 12SEC filing · Form 8-K-1.20%-6.35%
Form 8-K BridgeBio Pharma, Inc. For: Sep 10SEC filing · Form 8-K+0.52%-3.88%
Form 8-K BridgeBio Pharma, Inc. For: Aug 16SEC filing · Form 8-K+1.17%-0.16%
Form 10-Q BridgeBio Pharma, Inc. For: Jun 30SEC filing · Form 10-Q+2.58%+7.34%
Form 8-K BridgeBio Pharma, Inc. For: Aug 01SEC filing · Form 8-K-1.43%+1.00%
Form S-8 BridgeBio Pharma, Inc.SEC filing · Form S-8+2.58%+7.34%
Form 8-K BridgeBio Pharma, Inc. For: Jul 23SEC filing · Form 8-K+0.18%-2.98%
Form 8-K BridgeBio Pharma, Inc. For: Jun 21SEC filing · Form 8-K-1.34%+0.91%
Form 8-K BridgeBio Pharma, Inc. For: Jun 04SEC filing · Form 8-K-1.21%-2.48%
Form 10-Q BridgeBio Pharma, Inc. For: Mar 31SEC filing · Form 10-Q+0.10%-2.18%
Form 8-K BridgeBio Pharma, Inc. For: May 02SEC filing · Form 8-K-1.96%+0.51%
Form ARS BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form ARS-0.45%+1.63%
Form DEF 14A BridgeBio Pharma, Inc. For: Jun 21SEC filing · Form DEF-0.45%+1.63%
Form DEFA14A BridgeBio Pharma, Inc.SEC filing · Form DEFA14A-0.45%+1.63%
Form 8-K BridgeBio Pharma, Inc. For: Mar 05SEC filing · Form 8-K+0.71%+1.66%
Form 8-K BridgeBio Pharma, Inc. For: Mar 01SEC filing · Form 8-K-2.78%-10.03%
Form 10-K BridgeBio Pharma, Inc. For: Dec 31SEC filing · Form 10-K+0.15%-1.02%
Form 8-K BridgeBio Pharma, Inc. For: Feb 22SEC filing · Form 8-K+1.80%-0.80%
Form 8-K BridgeBio Pharma, Inc. For: Jan 17SEC filing · Form 8-K-0.77%-0.03%
Form 8-K BridgeBio Pharma, Inc. For: Jan 08SEC filing · Form 8-K+2.25%+5.05%
Form S-8 BridgeBio Pharma, Inc.SEC filing · Form S-8-1.04%+3.56%
Form 10-Q BridgeBio Pharma, Inc. For: Sep 30SEC filing · Form 10-Q+1.45%+4.57%
Form 8-K BridgeBio Pharma, Inc. For: Nov 02SEC filing · Form 8-K+0.99%+0.56%
Form S-3ASR BridgeBio Pharma, Inc.SEC filing · Form S-3ASR+1.45%+4.57%
That’s how BBIO usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More BBIO: earnings → · analyst actions → · BBIO overview →